These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207 [TBL] [Abstract][Full Text] [Related]
5. [Depressive pseudodementia in early Parkinson's disease: lessons from a case with long-term follow-up]. Giménez-Roldán S; Mateo D; Dobato JL Neurologia; 1997 Mar; 12(3):130-5. PubMed ID: 9198454 [TBL] [Abstract][Full Text] [Related]
6. The interlocking finger test in patients with Parkinson's disease and healthy subjects. Souza CP; Oliveira GN; Foss MP; Tumas V J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261 [TBL] [Abstract][Full Text] [Related]
9. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203 [TBL] [Abstract][Full Text] [Related]
10. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia. Ojagbemi A J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316 [TBL] [Abstract][Full Text] [Related]
11. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset. Hanna-Pladdy B; Pahwa R; Lyons KE J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830 [TBL] [Abstract][Full Text] [Related]
12. Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study. Arie L; Herman T; Shema-Shiratzky S; Giladi N; Hausdorff JM J Neurol; 2017 Oct; 264(10):2149-2157. PubMed ID: 28879438 [TBL] [Abstract][Full Text] [Related]